Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy.

Boyero, Laura; Sánchez-Gastaldo, Amparo; Alonso, Miriam; Noguera-Uclés, José Francisco; Molina-Pinelo, Sonia; Bernabé-Caro, Reyes

Boyero, Laura; Sánchez-Gastaldo, Amparo; Alonso, Miriam; Noguera-Uclés, José Francisco; Molina-Pinelo, Sonia; Bernabé-Caro, Reyes.

Afiliação

Boyero L; Institute of Biomedicine of Seville (IBiS) (HUVR, CSIC, Universidad de Sevilla), 41013 Seville, Spain.
Sánchez-Gastaldo A; Medical Oncology Department, Hospital Universitario Virgen del Rocio, 41013 Seville, Spain.
Alonso M; Medical Oncology Department, Hospital Universitario Virgen del Rocio, 41013 Seville, Spain.
Noguera-Uclés JF; Institute of Biomedicine of Seville (IBiS) (HUVR, CSIC, Universidad de Sevilla), 41013 Seville, Spain.
Molina-Pinelo S; Institute of Biomedicine of Seville (IBiS) (HUVR, CSIC, Universidad de Sevilla), 41013 Seville, Spain.
Bernabé-Caro R; Medical Oncology Department, Hospital Universitario Virgen del Rocio, 41013 Seville, Spain.

Cancers (Basel) ; 12(12)2020 Dec 11.

Article em En | MEDLINE | ID: mdl-33322522

Palavras-chave

NSCLC; PD-1/PD-L1; SCLC; immune checkpoint inhibitors; immunotherapy; lung cancer; monoclonal antibodies; resistance mechanisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google